Biologics Development and Manufacturing Trends, Part 2

Published on: 

PharmTech Multimedia

Eric Langer, Managing partner at BioPlan Associates, speaks with Pharmaceutical Technology about biosimilar development trends.

Eric Langer, Managing Partner at BioPlan Associates, spoke with Pharmaceutical Technology about biosimilar development trends. 

 

Related Content:

Biologic DrugsManufacturingDosage Forms
Ross Announces PFA-Coated Ribbon Blender to Be Offered for Sensitive Applications
CordenPharma Selects Switzerland Site for Peptide Manufacturing Facility
Developments in Aseptic Processing